Epivax is a startup based in the United States.
Epivax develops computational immunology tools and provides epitope-based vaccine design and immunogenicity assessment services to support vaccine and therapeutic development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.